Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-11-20

FDA Approved: RADIOGARDASE — Supplemental Application (Heyl Chem.-pharm. Fabrik GmbH & Co. KG)

View source ↗

Summary

FDA approved a supplemental application for Radiogardase (Prussian blue insoluble capsules) from Heyl Chem.-pharm. Fabrik, representing regulatory approval of a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Radiogardase (Prussian blue insoluble capsules)

Snippet

SUPPL AP for RADIOGARDASE (PRUSSIAN BLUE INSOLUBLE CAPSULES)